Chromatin immunoprecipitation (ChIP) has become a widely used method for studying how proteins interact with the genome. The ChIP technique identifies physical interactions between proteins and DNA that occur within living cells [1] [2] [3] and ChIP can provide a whole-genome view of protein-DNA interactions when combined with DNA microarray analysis [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Our goal here is to share our ChIP-Chip protocol, suggest useful quality-control tests, identify the most likely sources of trouble and suggest solutions to problems with experiments. The protocol presented here has been in use for several years and has been used by many different individuals using a broad range of different mammalian cell types and tissues.
INTRODUCTION
DNA microarray platforms are expensive. As array manufacturers continue to make improvements in designs and manufacturing, more cost-effective experiments will be possible. Finally, the experimental process is long and can be challenging to troubleshoot.
Experimental design
Background. The sections below describe several issues that we have found to be critical to consider in the early stages of planning and designing ChIP-Chip experiments.
Antibodies. ChIP-Chip is highly dependent on the antibody used for the immunoprecipitation. As individual antibodies can perform differently in the ChIP assay, it is helpful to screen a wide variety of available antibodies before launching a fullscale ChIP-Chip experiment. We generally start with antibodies, for which there is previous evidence for use in ChIP, or we use a variety of polyclonal and monoclonal antibodies from several sources.
The most reliable way to test the antibodies is to use them in small-scale ChIPs and to test for enrichment at a gene-specific level, although this approach depends entirely on the number of known binding sites, the strength of the evidence for the binding event and the comparability with your specific cell type, growth conditions and treatments. For small-scale ChIPs, we prepare material as described below, but instead of using all the material for a single reaction, we will split it into five to ten aliquots and use each aliquot in an immunoprecipitation. This lower amount of material seems adequate for gene-specific analysis, but does not usually work for microarray analysis. If no binding sites are known, it is much more difficult to screen for a useful antibody. Western blot analysis may be informative but is unreliable, as the antibody may recognize the denatured protein in a western blot but may still fail to recognize the native form in vivo.
If there are no antibodies for a specific protein, it is possible to use epitope-tagged versions of proteins, provided the tagged version does not radically affect protein function. We have used myc, TAP and FLAG epitope-tagged versions of various proteins with success.
Reference samples. Chromatin immunoprecipitation is an enrichment relative to a reference and not an absolute measurement, thus the choice of reference sample can be an important element of experimental design. Although it is most common to use unenriched, genomic DNA as the reference, it is sometimes more useful to hybridize an immunoprecipitation of one factor against an immunoprecipitation of a second factor to capture subtle effects. For instance, this approach can be useful when studying histone modifications. An immunoprecipitation against a core histone subunit is used as the reference to normalize the signal of the modification against the amount of histone. This can help to determine whether a perceived gain or loss of the modification is due to actual changes in modification or due to changes in histone density.
Replicates. ChIP-Chip, like many other forms of genomewide analysis, requires the use of replicate samples to account for experimental noise that is inherent to high-throughput approaches and biological complexity due to the many factors influencing protein and nucleic-acid interactions. In particular, biological replicates (independently grown and treated pools of cells or tissue) or replicates with different antibodies against the same factor are valuable. The number of replicates needed depends on the noise that is inherent in the platform and the type of analysis to be performed, but triplicate experiments are preferred and duplicate experiments should be considered to be the minimum requirement whenever feasible.
Experimental controls. The use of a positive control and negative control for the experiment can be useful, both for troubleshooting and for calibrating the analysis. The positive control should be a high-quality antibody against a protein that is likely to be present in any cell type. For example, in mammalian cells, we regularly use antibodies against the ubiquitous cell-cycle regulator E2F4. The most common negative control is an immunoprecipitation using a non-specific antibody that matches the isotype of the experimental antibody.
Choice of arrays. There are a number of options available for array hybridization, including self-printed oligonucleotide or PCR amplicon arrays, and commercial arrays and services. The choice of array platform ultimately depends on the need to balance per-formance, ease of use, resolution, cost of arrays and investment in equipment, and will vary from lab to lab. Due to the variety of options, a fully detailed protocol for our specific hybridization, washing, scanning and analysis steps is unlikely to be generally useful. However, we have included the relevant details for hybridization and washing and offer general guidelines that we try to follow for scanning and data analysis. This protocol was developed based on our work with both self-printed PCR amplicon arrays and commercially available oligonucleotide arrays, and reflects our most recent experience with oligonucleotide arrays 13, 14, 35, 36 . A number of useful ChIP-Chip protocols have been published that describe protocols similar to this one, but which cover more specific aspects of dealing with different array platforms [37] [38] [39] [40] [41] [42] [43] [44] .
Normalization controls on the array. As ChIP measures enrichment in one sample compared with another, it is essential to define an appropriate baseline for a particular experiment -one that reflects the signal from the background of all sequences from the whole genome and reflects lack of enrichment in the immunoprecipitation. This requirement can affect the sets of controls that are needed on the array. When there are a small number of features expected to show enrichment, the enrichment ratios of the majority of features can serve to represent the baseline level; the large size of this latter set strengthens the statistical significance of the enrichment. In other situations, for example, when examining RNA polymerase II binding at promoter regions using arrays focused only on promoter regions, we found that it was more difficult to determine the baseline enrichment that represented 'no binding' . RNA polymerase II bound at a relatively high fraction of probes, making it more difficult to distinguish bound and unbound probes with as high a degree of statistical significance. In these cases, we found it useful to have a set of control probes designed against 'gene deserts' , genomic regions that are devoid of known open reading frames and for which there is no evidence of noncoding transcripts. We assumed that these control probes would be generally unenriched for RNA polymerase II and could therefore serve as a normalization baseline. Similarly, we use control probes to subtract out a baseline level of non-specific hybridization signal and, for multislide arrays, control probes to normalize between slides.
Data analysis and bioinformatics. The ChIP-Chip analysis generates a large amount of data that requires some investment in statistical, computational and bioinformatics infrastructure.
Statistical analysis is required to account for experimental noise that is inherent to high-throughput approaches, but more importantly, to deal with the biological complexity of protein and nucleic-acid interactions. We expect that a protein of interest will be distributed across many different sites in a single cell in a manner that is dependent on protein concentration, its affinities for each site and other variables such as the presence of proteins that compete for similar sites. As a result, the output of ChIP-Chip is a distribution of enrichment ratios representing DNA or RNA occupancy, as opposed to two distinct sets of 'bound' and 'not bound' . Statistical methods are needed to identify the statistically significant set of enrichment ratios, to provide a measure of confidence at the level of individual probe features and to incorporate data from multiple features to build models for binding that are both sensitive and specific. As there are a wide variety of options for statistical analysis 7, 12, [45] [46] [47] [48] [49] [50] [51] and the needs of individual labs will vary, a fully detailed description of our analysis methods is unlikely to be generally useful. However, we have included a basic outline of the approach that we have used in the past.
The volume and complexity of the data from ChIP-Chip analysis may require access to resources that are capable of creating or adapting programming code to manipulate and analyze the data. Even if most of the early steps are handled by a commercially available analysis package, there is almost always a need for additional analyses that need to be customized in some way. The capacity to handle and display the data using common programming languages, such as Visual Basic, MATLAB, Perl, R, Java or Python, is highly useful.
Along these lines, the need to be able to map ChIP-Chip data back to genomic location and genomic features often requires the development of bioinformatics resources, such as access to genome annotation and transcription-factor databases, and the ability to handle and cross-reference genome-wide expression data. Commonly used databases include the UCSC Genome Browser (http://genome. ucsc.edu/); the NCBI databases (http://www.ncbi.nlm.nih.gov/), particularly RefSeq, Gene and GEO datasets; the EMBL-EBI databases (http://www.ebi.ac.uk/services/); GO functional annotation (http://www.geneontology.org/); and TRANSFAC (http://www. gene-regulation.com/pub/databases.html).
Protocol Tips
Background. The sections below describe a few key steps of the protocol for which we have some experience with variables that are particularly critical to the success of the experiment. The steps are presented in order, with those most likely to cause problems being presented first.
Sonication. Sonication is the most variable step in the process and will vary greatly depending on cell type, cell culture conditions used, quantity of cells, volume of sonication, degree of crosslinking and specifics of the sonicator being used. As a result, conditions must usually be optimized for each situation. Sonication fulfills two roles, solubilization of chromatin and shearing of chromatin, both of which are essential for successful ChIP analysis. Solubilization is achieved relatively easily. However, the degree of shearing requires more care. Undersonication results in a loss of resolution of binding events. Smaller DNA fragments allow for more precise localization of a specific binding event, as a smaller region of DNA will be pulled down in the immunoprecipitation. We have also found that oversonication must be avoided as it results in more noise in the microarray analysis and difficulty in identifying legitimate targets. As a guide, most protocols suggest sonication until reaching an average fragment size (different protocols suggest a value varying from 350 to 1,000 bp) or until the fragment sizes are within a certain range. Undersonication relative to these kinds of guidelines is easy to identify: the size of the reverse crosslinked, purified DNA fragments will be too large. Oversonication is more difficult to quantify. Most crosslinked material has a physical limit of sonication, and additional sonication past this point will not result in further visible shearing but will affect microarray results. Thus, it is possible that researchers trying to match previously published descriptions that were optimized for different conditions may inadvertently oversonicate their DNA. As an alternative, we suggest sonication using the lowest power and time settings that result in sheared DNA, of which at least a quarter of the total DNA is sized from 200 to 600 bp in size, with less emphasis on the average size or overall spread of fragment sizes. One way to identify these conditions is to run a small time course of sonications. We will set up a sample of cells, as described below, with a default power setting but with an extended time of sonication. We then remove small aliquots (100 µl out of 3.5 ml of material) at discrete time points. After crosslink reversal and purification, as described in the protocol below, the DNA can be run on a 2% agarose gel to estimate the degree of sonication. A sample sonication time course is shown in Figure 2 .
Immunoprecipitation conditions. Antibody performance can be optimized by adjusting a number of variables, but we find that the simplest, most effective adjustment has been modifying the amount of salt in the immunoprecipitation. If gene-specific or Crosslinking. In practice, we have found that the crosslinking times and formaldehyde concentrations provided in this protocol are generally applicable and have been used successfully with a variety of proteins in human, mouse, yeast, fruit fly and zebrafish model systems. But crosslinking times could theoretically be optimized for each protein. Insufficient crosslinking can result in the inability to capture protein-DNA contacts. Over-crosslinking can actually denature the protein of interest or cause over-aggregation, thus obscuring the epitope. Unfortunately, these problems are sometimes difficult to diagnose as the primary readout is the failure to detect enrichment, which could also result in problems at any number of other steps. One other sign would be unusual ease or difficulty in obtaining a range of sonicated material when testing a range of sonication conditions. • BioPrime Array CGH Genomic Labeling System (Invitrogen; Cat. no.: 18095-011; includes Labeling Module and Purification Module) ▲ CRITICAL We have experimented with other purification methods, but have found that these kits gave us the best yield while efficiently removing smaller DNA products. We have found that these small DNA products increased the background noise at lower signal intensity levels on our arrays. ! CAUTION This solution contains acetonitrile, which is flammable and hazardous and should be used in a fume hood. EQUIPMENT • Cell strainer, 100 µm nylon (if using tissues) (e.g., BD Falcon)
MATERIALS

REAGENTS
• Rotator (e.g., Fisher Hematology/Chemistry Mixer)
• Magnetic particle collector (MPC; Dynal)
• Sonicator (e.g., Misonix 3000 sonicator equipped with microtip)
• Phase lock, heavy, pre-dispensed into 2.0 ml microfuge tubes (Eppendorf) (Although these could be replaced with standard liquid organic solvent extractions, the ease of use factor makes these ideal) • NanoDrop ND-1000 spectrophotometer (This is highly useful as it allows you to assay DNA concentrations and dye incorporations by using low volumes (1. The settings we typically begin with are power setting 7 (~35 W) and 12 cycles (where each cycle is a 30 s burst of sonication, followed by a 90 s pause). The range of settings will vary based on cell type, cell number, growth conditions and crosslinking. For comparison, the range of settings we have used for specific experiments is: power settings from 6 to 9; cycle number from 8 to 15; burst times of 20 to 30 s and pause times of 60 to 90 s. Array scanning As the specifics of scanning depend on the platform chosen and the scanner available, it is less useful to provide a detailed protocol on how to scan arrays using any one specific set-up. However, there are a few guidelines that we have found to be useful for two-color hybridizations. In selecting scanner settings, the primary variable we change is photomultiplier tube (PMT) gain, which adjusts the sensitivity of the PMT that converts photons to a digitized electrical signal for the Cy3 and Cy5 channels.
PROCEDURE Formaldehyde crosslinking cells • TIMING Day 1, 1-4 h 1|
For formaldehyde-crosslinking of cells, three procedures are described that can be used, depending on whether your cells are: adherent to culture apparatus (A); growing in suspension (B); or obtained fresh from tissues (C). The procedure given in (C) has been used with mouse and human tissues. Specifics vary from tissue to tissue, and this extraction procedure will therefore require some optimization -these steps are, therefore, general guidelines for extracting and crosslinking cells from tissues.
! CAUTION See REAGENTS for precautions when using formaldehyde. 2| Flash-freeze cells in liquid nitrogen and store pellets at -80 °C. ■ PAUSE POINT Once cells are crosslinked, they may be stored frozen at -80 °C indefinitely.
Preparing magnetic beads • TIMING Day 2, 7-8 h 3|
Add 100 µl of Dynal beads to a 1.5 ml microfuge tube. Set up 1 tube of beads per immunoprecipitation. Add 1 ml Block Solution. ▲ CRITICAL STEP Steps 3-9 are all performed at 4 °C.
A higher PMT gain creates a brighter image. We try to select PMT settings for each of the lasers in a two-color scanner that maximize signal intensity from features, without creating excessive background signal from the glass surface. Our current array platform has extremely low background signal, so our main concern is maximizing signal intensity. PMT gains are also set such that the distributions of signal intensities for each channel are similar. In addition, the settings should not result in a large number of signals that exceed, and are therefore thresholded at, the maximum detection range of the scanner. This can result in loss of detection of enrichment for features with high signal intensities. 
4|
Collect beads using Dynal MPC. Place tubes in rack. Allow beads to collect on side of tube. This should take approximately 15
14|
Resuspend each pellet in each tube in 3.5 ml Lysis Buffer 3. Transfer cells to tubes for sonication. We currently prefer to use the bottom half of a standard polypropylene, 15 ml conical tube for sonication. We cut the tube into two pieces at the 7 ml mark and discard the upper half. Tubes can be covered with parafilm while setting up. You may also wish to save a 50 µl aliquot for use as a pre-sonication control.
15| Using a clamp, position tube so the sonicator probe sits approximately 0.5-1.0 cm above the bottom of the tube. Take care that the probe is centered and does not contact the sides of the tube. ▲ CRITICAL STEP Probe positioning can affect whether the solution foams or not during sonication. Typically, foaming indicates that the sonicated DNA will be poorly sheared. ? TROUBLESHOOTING 16| Immerse tube in an ice-water bath. This is most easily done by keeping the sonicator probe and tube fixed, placing the bath on a height-adjustable platform and raising it into position.
17| Sonicate suspension. Samples should be kept in an ice-water bath during sonication. To decrease foaming, initially set output power to 4 and increase manually to final power during first burst. ▲ CRITICAL STEP If there is significant foaming, we recommend removing all bubbles by centrifugation at 20,000g followed by gentle resuspension of all material, leaving no foam bubbles. ? TROUBLESHOOTING 18| Add 1/10 volume of 10% Triton X-100 to sonicated lysate. Split into two 1.5 ml centrifuge tubes. Spin at 20,000g for 10 min at 4 °C to pellet debris.
19|
Combine supernatants from the two 1.5 ml centrifuge tubes in a new 15 ml conical tube for immunoprecipitation. ▲ CRITICAL STEP From here on, keep lysates on ice.
20|
sonicated lysate. Note that the effects of the sonication and the resulting distribution of fragment sizes can only be checked at Step 42 after crosslink reversal and purification of DNA. ■ PAUSE POINT Lysates can be frozen at -80 °C and used the next day.
Chromatin immunoprecipitation • TIMING Day 2, 15 min and overnight incubation 21| Add 100 µl antibody/magnetic bead mix from Step 9 to cell lysates from Step 19. Incubate overnight on rotator at 4 °C. ▲ CRITICAL STEP Antibody performance can be affected by the amount of salt in the reaction. If there is previous evidence indicating specific salt conditions that are optimal for a particular antibody, we will supplement the lysate with additional sodium chloride to approximate those conditions. In this case, the salt concentrations of wash buffers used in Steps 25-26 should also be adjusted. ? TROUBLESHOOTING Wash • TIMING Day 3, 2 h 22| Set up 1.5 ml microfuge tubes on ice, one tube for each immunoprecipitation. Transfer half of each immunoprecipitation from the 15 ml conical tube to its assigned microfuge tube. ▲ CRITICAL STEP All wash steps are performed at 4 °C. Buffers should be kept cold. Crosslink reversal • TIMING Day 3, 6 h or overnight 31| Reverse crosslink the immunoprecipitation DNA from Step 30 by incubating at 65 °C for a minimum of 6 h. This incubation is usually done in an oven so that the tube is heated evenly and there is less condensation formed. ? TROUBLESHOOTING 32| Thaw 50 µl of input DNA reserved after sonication (Step 20), add 150 µl (3 volumes) of elution buffer and mix. Reverse crosslink this input DNA by incubating at 65 °C as in Step 31. From this point, every tube of immunoprecipitation or input DNA is considered to be a separate tube or sample for later processing steps. ■ PAUSE POINT If the wash was performed early in the day, the crosslink reversal can be stopped after a minimum of 6 h and the material can be frozen at -20 °C and stored overnight. If the wash was performed later in the day, the crosslink reversal can be extended up to 15 h and performed overnight with little effect on the reaction. ▲ CRITICAL STEP Longer times of crosslink reversal (18 h or more) usually result in increased noise in the microarray analysis. ? TROUBLESHOOTING Purification of DNA • TIMING Day 4, 6 h 33| Add 200 µl of TE to each tube to dilute SDS in Elution Buffer. We have found that high levels of SDS can inhibit RNAse activity.
34| Add 8 µl of 10 mg ml -1 RNaseA (0.2 mg ml -1 final concentration), mix by inverting the tube several times and incubate at 37 °C for 2 h. ■ PAUSE POINT Material can be frozen at -20 °C and stored overnight.
35| Add 4 µl of 20 mg ml -1 Proteinase K (0.2 µg ml -1 final concentration) and mix by inverting the tube several times and incubate at 55 °C for 2 h.
36|
Add 400 µl phenol:chloroform:isoamyl alcohol (P:C:IA), vortex and separate phases with 2 ml Heavy Phaselock tube (follow instructions provided by Eppendorf). ▲ CRITICAL STEP If the P:C:IA solution is old or is at low pH, there will be degradation of DNA, causing noise in the microarray analysis and loss of detection of valid targets. ! CAUTION see REAGENTS for precautions when using phenol and chloroform. ? TROUBLESHOOTING 37| Transfer aqueous layer to new centrifuge tube containing 16 µl of 5M NaCl (200 mM final concentration) and 1.5 µl of 20 µg µl -1 glycogen (30 µg total).
38| Add 800 µl EtOH. Incubate for 30 min at -20 °C.
39| Spin at 20,000g for 10 min at 4 °C to pellet DNA. Wash pellets by adding 500 µl of 80% EtOH, vortexing to resuspend pellet and spinning again at 20,000g for 5 min at 4 °C.
40|
Remove any remaining 80% EtOH. Spin the tubes briefly to collect any remaining liquid and remove liquid with a pipetteman, avoiding the pellet. Let tubes air dry until pellets are just dry: pellets should still retain a moist appearance. Resuspend each pellet in 70 µl of 10 mM Tris-HCl, pH 8.0. ▲ CRITICAL STEP Overdrying of these pellets can make them difficult to resuspend, or liable to flake and peel away from the side of the tube. ? TROUBLESHOOTING 41| Save 15 µl of immunoprecipitation sample for future use. This material can be used to perform gene-specific PCR confirmation of microarray results.
42|
Measure DNA concentration of input DNA with NanoDrop and dilute input DNA to 100 ng µl -1 . Run purified input DNA on a 2% agarose gel to check distribution of fragment sizes and digestion of RNA. The immunoprecipitation DNA will usually be too dilute to measure or visualize at this point. If possible, this is a good opportunity to check for enrichment in the immunoprecipitation sample using gene-specific PCR. ■ PAUSE POINT Material can be frozen at -80 °C and stored indefinitely. 49| Spin at 20,000g for 10 min at 4 °C to pellet DNA. Wash pellets by adding 500 µl of 80% EtOH, vortexing to resuspend pellet and spinning again at 20,000g for 5 min at 4 °C.
50|
Remove any remaining 80% EtOH. Spin the tubes briefly to collect any remaining liquid and remove liquid with a pipetteman, avoiding the pellet. Let tubes air dry until pellets are just dry: pellets should still retain a moist appearance. ▲ CRITICAL STEP Overdrying of these pellets can make them difficult to resuspend, or liable to flake and peel away from the side of the tube. ? TROUBLESHOOTING 51| Carefully resuspend each pellet in 25 µl H 2 O with pipetting. Adding the water and then allowing the pellets to sit on ice for some time can help. Chill on ice after resuspending. ■ PAUSE POINT Material can be frozen at -80 °C and stored indefinitely. 70| While reagents are cooling, make up Label Mix. One mix is required for immunoprecipitation samples (usually Cy5). A second mix is required for input DNA samples (usually Cy3). If reagents permit, a dye swap can provide a useful comparison (a second set of replicates where the immunoprecipitate is labeled with Cy3 and the input DNA is labeled with Cy5). 73| Incubate samples for 3 h at 37 °C. ▲ CRITICAL STEP Keep samples in dark as Cy dyes are sensitive to exposure to light. Other incubation times and conditions have been tried, but we find that these conditions offer the best yield, while limiting the accumulation of smaller DNA fragments (<100 bp) that can contribute to noise in the microarray analysis.
Blunt-end ligation
74| Add 9 µl stop buffer to each well and mix by pipetting gently.
75|
Clean up DNA using the DNA purification columns provided with the CGH kit. Follow manufacturer's instructions. ? TROUBLESHOOTING 76| After eluting labeled DNA from the column into a microfuge tube, spin tubes at 15,000g for 2 min at room temperature to pellet any fine particulates. Carefully transfer supernatants to fresh tubes. Repeat if necessary to ensure that the solution is clear. ▲ CRITICAL STEP It is particularly important to thoroughly remove the particulates at this step. Particulates from the purification column can bind to some slide surfaces, making it difficult, if not impossible, to successfully scan the slide.
? TROUBLESHOOTING
77|
Measure DNA concentration and dye incorporation with NanoDrop. Optional: Run a 2% agarose gel to check size of labeling products. ■ PAUSE POINT If this DNA is going to be used within the next day, it can be stored at -20 °C. If the DNA will be stored for longer, we recommend storing it as a pellet. Precipitate the DNA by adding 25 µl of ammonium acetate and 300 µl of ice-cold EtOH and placing the tubes at -80 °C for 10 min. Spin at 20,000g for 10 min at 4 °C to pellet DNA. Wash pellets with 500 µl of 80% EtOH. Remove excess ethanol. Allow pellets to air-dry briefly and store tubes at -80 °C in a lightproof box or wrapped in aluminum foil. 
Array washing • TIMING Day 8, 1-2 h 89|
Before disassembling hybridization chambers, prepare Wash I (6× SSPE, 0.005% H-lauroylsarcosine) and Wash II (6× SSPE). Filter Wash I and Wash II before use. Place Wash III at 37 °C to dissolve solute. Swirling the bottle of Wash III occasionally will help to dissolve the solute. Allow the solution to cool to room temperature before use. ! CAUTION As Wash III is volatile, avoid temperatures that are higher than 45 °C. ? TROUBLESHOOTING
90|
Prepare and wash all glassware and equipment that is required for slide disassembly (follow manufacturer's instructions) and for washes described in Steps 91-95. We usually use standard glass 10-slide microscope slide racks and dishes. ? TROUBLESHOOTING 91| After hybridization, disassemble hybridization chambers individually following the manufacturer's instructions. Batches of 4-6 slides are convenient. Slides are placed in slide racks in dishes containing a magnetic stir bar (thin enough to spin freely when slides and slide rack are added) and sufficient Wash I to cover the slides.
? TROUBLESHOOTING 92| Once all slides for this batch are in the dish, place dish on stir plate and gently stir for 5 min at room temperature. On a typical stir plate with settings from 1 to 10, use setting 3 or 4. 14 . Scan slides (we use an Agilent DNA microarray scanner) at wavelengths of 532 nm for input (Cy3) and 635 nm for enriched (Cy5).
100|
Use GenePix feature-identification software to automatically identify features and to extract data for fluorescence at each wavelength by calculating the average intensities for all pixels within the feature boundaries.
101|
Subtract local background signal for each feature. Normalize the signal intensities of the slide across the entire set of slides using signals from a set of common features that are printed on every slide in the set. Then, subtract the signal intensities from a set of negative controls for hybridization.
102|
Median normalize the data from the two channels and generate a log ratio of signal intensities for each feature.
103|
Process the log ratios using a whole chip error model 52 , which incorporates signal intensity and background noise to calculate a P-value for the statistical significance of the enrichment ratio that is seen at each feature. We also calculate the P-value for enrichment for sets of three adjacent features and incorporate information about the enrichment at both individual features and sets of features to identify genomic regions that qualify as being bound by the protein in question. ? TROUBLESHOOTING
104|
Identify distinct binding events by collapsing adjacent bound regions.
• 
TROUBLESHOOTING
Troubleshooting advice can be found in Table 1 . 
ANTICIPATED RESULTS
Step 42 (i) Measure DNA concentration of input DNA (from Step 20) with NanoDrop. Input DNA samples should be approximately 70 µl total volume with a DNA concentration of 300-500 ng µl -1 . Immunoprecipitation samples are usually too dilute to detect reliably and measurements are sometimes skewed due to the glycogen that is added to the sample, but we have pooled and precipitated several immunoprecipitates and, after adjusting for changes in volume, expect a DNA concentration of 2-6 ng µl -1 . The immunoprecipitated DNA concentration may be higher if the immunoprecipitation is directed against an abundant protein.
Step 42 (ii) Run a 2% agarose gel of the input DNA that is saved prior to immunoprecipitation (Step 20) . This allows you to visually check the distribution of fragment sizes that result from sonication, and to confirm digestion of RNA. Examples of different distributions of fragment sizes resulting from different degrees of sonication are shown in Figure 2 . We would first try ChIP with the fragment distribution that is seen with 12 cycles of sonication, as this is the lowest amount of sonication that results in a majority of fragments, ranging from 200-600 bp. The fragment distribution that is seen with eight cycles of sonication is also likely to yield reasonable ChIP results, but this material has generally larger fragments that could reduce the ability to resolve binding events. The fragment distribution that is seen with 16 cycles of sonication is similar to the 12-cycle material, but we would default to the lower amount of sonication. Note that different cell types, growth conditions and crosslinking conditions will change the appearance of similar sonication time courses. However, the basic principle of finding a setting that minimizes sonication while maximizing fragments in the range of 200-600 bp should still be a useful starting point.
It can also be useful to calculate the fragment-size distribution more precisely with laser densitometry or a device such as the Agilent 2100 Bioanalyzer. These values are useful for computational algorithms that combine knowledge of the size distribution with genomic probe locations, probe characteristics and enrichment ratios to develop more sophisticated models of protein-DNA binding.
Step 42 (iii) Whenever possible, you should check that the immunoprecipitation was successful by looking for enrichment of known positive controls in the immunoprecipitated DNA sample. This is most easily done by performing PCR using primers for known positive control and negative control regions and running the products on an agarose gel. Compare the ratio of DNA for the positive control versus the negative control for both the immunoprecipitated DNA (use 2 µl) and the input DNA (use dilution series). The immunoprecipitation positive:negative ratio should be at least twice the input DNA positive:negative ratio. It is important to perform a serial dilution of the input DNA PCR reactions to ensure that all of the reactions are in the linear range of detection. Ideally, we run the reactions as a multiplex PCR so the expected positive and the negative control are being tested in the same PCR reaction (adjust primer concentrations so the input DNA positive:negative ratio is close to 1). This is not always possible with every combination of primers.
Step 64 (i) Measure DNA concentration with NanoDrop. DNA samples should be approximately 50 µl total volume with a DNA concentration of 100-350 ng µl -1 . All samples, immunoprecipitated and input DNA should be comparable in DNA amounts.
Step 64 (ii) Run a 2% agarose gel of the LMPCR DNA. DNA products should be centered around 200-400 bp. All samples, immunoprecipitated and input DNA should be comparable in distribution of fragment sizes and DNA amounts. An example of LMPCR DNA run on an agarose gel is shown in Figure 3 . Step 77 (i) Measure DNA concentration and dye incorporation with NanoDrop. DNA samples should be approximately 50 µl total volume with a DNA concentration of 100-150 ng µl -1 and 4-10 pmol µl -1 of incorporated dye.
Step 77 (ii) Run a 2% agarose gel of the labeled, purified DNA. DNA products should be centered around 200-300 bp. There should not be significant amounts of DNA fragments that are smaller than 100 bp in the purified sample. An example of labeled DNA run on an agarose gel is shown in Figure 3 .
Step 98 A sample region of a scanned array is shown in Figure 4 . Arrays should have a clean and uniform background, with little particulate debris or dust. Features should be evenly arranged and have a uniform shape. Typically, we label immunoprecipitated material with Cy5 and input DNA material with Cy3, and set array visualization so that Cy5 signals appear red and Cy3 signals appear green. Thus, for a successful immunoprecipitation, we expect a subpopulation of red spots, indicating features that have been enriched in the immunoprecipitation channel. We expect few, if any, non-control features that appear bright green, indicating features enriched in the input DNA channel. We expect the majority of spots to be yellow or yellowish-green, indicating no enrichment. Note that this assumes there are relatively few binding events and that the array has been scanned to balance the distributions of signal intensities in the two channels.
Step 104 Figure 5 shows a progression of data from array signal to identification of genomic regions that have been enriched for binding to verification by gene-specific PCR. The array images (Fig. 5a,d ) are from slides that were part of a multislide, whole-genome array that detects binding of the initiating form of RNA polymerase II. The slides were scanned and processed, as described, to generate ratios of signal intensities. The subsequent ratios were processed to identify significantly enriched features and binding events. When we plot enrichment ratios against chromosomal position of array features, we expect binding events to have two basic characteristics (Fig. 5b) . Features identifying a binding event should show significantly higher enrichment ratios than background. Observed enrichment ratios generally range from 2-fold to 15-fold, although ratios will vary based on antibody performance and can be as high as 80-fold in some cases. Binding events should be supported by multiple features: two or more adjacent features should both indicate enrichment above background. The number of probes that are expected to identify a binding event will depend on the degree of sonication, which influences the size of DNA fragments in the ChIP and the tiling density of the array, which affects the average number of probes that could reasonably detect immuno-enriched fragments, given the distribution of fragment sizes and whether the protein binds over large or small regions. Legitimate binding events can also be confirmed by PCR (Fig. 5c) . PCR should be performed using primers that are designed to amplify the genomic regions that are bound and run the products should be run on an agarose gel. The signals that are generated using the immunoprecipitated DNA sample should be compared to the signal generated using the input DNA sample. There should be more signal in the immunoprecipitated DNA sample when equivalent amounts of immunoprecipitated DNA and input DNA are used in the PCR. A serial dilution of the input DNA PCR reactions should be performed to ensure that all of the reactions are in the linear range of detection.
